Organ Preservation Market

Organ Preservation Market Size:

The global organ preservation market size reached US$ 187.9 Million in 2023. Looking forward, IMARC Group expects the market to reach US$ 313.4 Million by 2032, exhibiting a growth rate (CAGR) of 5.7% during 2024-2032. The market is experiencing stable growth driven by increasing prevalence of organ failures due to chronic disorders, such as liver disease, kidney issues, inflammatory bowel disease, and asthma, shortage of donor organs, and the improving healthcare infrastructure.

Organ Preservation Market Analysis:

• Major Market Drivers: The market is witnessing moderate growth due to the increasing awareness about the importance of organ preservation, coupled with advancements in organ preservation technologies.
• Key Market Trends: The market is showcasing rapid growth on account of the rising prevalence of organ failure and shortage of donor organs.
• Geographical Trends: North America leads the market, driven by the presence of well-established healthcare infrastructure. However, Asia Pacific is emerging as a fast-growing market due to increasing organ transplant procedures.
• Competitive Landscape: Some of the major market players in the organ preservation industry include 21st Century Medicine Inc., Biolife Solutions Inc., Bridge to Life Ltd., Bristol-Myers, Dr. Franz Köhler Chemie GmbH, Essential Pharmaceuticals LLC, Lifeline Scientific Inc., OrganOx Ltd., Paragonix Technologies Inc., Transmedics, Inc., Waters Medical Systems LLC, Xvivo Perfusion., among many others.
• Challenges and Opportunities: While the market faces challenges, such as quality assurance, it also encounters opportunities on account of partnerships between academic institutions, research organizations, and key manufacturers.
   

Organ Preservation Market Trends:

Rising Prevalence of Organ Failure

The increasing prevalence of organ failures due to chronic disorders, such as liver disease, kidney issues, inflammatory bowel disease, asthma, and chronic obstructive pulmonary disease (COPD), among the masses across the globe is offering a positive organ preservation market outlook. Organ failures are also caused due to traumatic injury, alcohol or drug use, and ischemia. People are suffering from these conditions due to changing lifestyles and dietary patterns of individuals. The Journal of the American Medical Association (JAMA) Network, reports that the number of COPD cases across the globe is anticipated to reach 592 million by 2050.

Shortage of Donor Organs

According to the Health Resources and Services Administration (HRSA), various patients waited for organs, such as 89,101 for kidney organ, 832 for pancreas organ, and 9,862 for liver organ in 2024. The shortage of donor organs is emphasizing the importance of organ preservation. The rising focus on preserving organs to improve patient outcomes is contributing to the growth of the market. Organ preservation plays a crucial role in lowering the impact of organ scarcity by extending the viability of organs during storage and transport.

Improving Healthcare Infrastructure

Healthcare facilities assist in providing enhanced care to individuals suffering from various diseases. In addition, the increasing number of organ transplant procedures in these facilities is bolstering the organ preservation market growth. Furthermore, there is a rise in the number of hospitals, clinics, specialized care centers in numerous countries worldwide, which is catalyzing the organ preservation market demand. For instance, the total number of hospitals in the United States recoded 65,129 in the financial year 2022, as reported by the American Hospital Association (AHA).

Organ Preservation Market Segmentation:

IMARC Group provides an analysis of the key trends in each segment of the market, along with organ preservation market forecast at the global, regional, and country levels for 2024-2032. Our report has categorized the market based on preservation solution, organ donation type, technique, organ type, and end-user.

Breakup by Preservation Solution:

• UW Solution
• Custodiol HTK
• Perfadex
• Others
   

UW solution accounts for the majority of the market share

The report has provided a detailed breakup and analysis of the market based on the preservation solution. This includes UW solution, custodiol HTK, perfadex, and others. According to the report, UW solution represented the largest segment.

University of Wisconsin (UW) solution provides superior preservation for kidney and other organs. The UW preservation allows longer and safer preservation of kidneys and livers, a higher rate of graft survival, and a lower rate of primary nonfunction. It is an intracellular preservation solution with low sodium and high potassium concentrations that mimic an intracellular environment. The rising adoption of UW solution for kidney preservation due to its superior properties as compared to EC solution is bolstering the growth of the market. Besides this, the increasing focus on preserving organs to fulfill the growing number of organ transplants is impelling the market growth. For example, a total 7,624 organ transplants were performed between January-February 2024 in the United States, as claimed by the Organ Procurement and Transplantation Network (OPTN).

Breakup by Organ Donation Type:

• Living Organ Donation
• Deceased Organ Donation
   

Deceased organ donation holds the largest share of the industry

A detailed breakup and analysis of the market based on the organ donation type have also been provided in the report. This includes living organ donation and deceased organ donation. According to the report, deceased organ donation accounted for the largest market share.

Deceased organ donation involves giving an organ or a part of an organ at the time of the death of the donor for the purpose of transplantation to another person. It provides lifesaving opportunities for individuals in need of organ transplants. The rising awareness among individuals about the importance of organ donation for saving human life is propelling the market growth. According to the Organ Procurement and Transplantation Network (OPTN), a total of 14,903 people became deceased organ donors in 2022, an increase of 7.5% as compared to 2021.

Breakup by Technique:

• Static Cold Storage Technique
• Hypothermic Machine Perfusion
• Normothermic Machine Perfusion
• Others
   

Static cold storage technique represents the leading market segment 

The report has provided a detailed breakup and analysis of the market based on the technique. This includes static cold storage technique, hypothermic machine perfusion, normothermic machine perfusion, and others. According to the report, static cold storage technique represented the largest segment.

Static cold storage technique is a widely utilized method for preserving organs, particularly for liver transplantation. It is an easily accessible preservation procedure that does not require complex equipment or specialized training. The rising adoption of static cold storage technique, as it offers enhanced logistical convenience and cost-effectiveness and works well with most transplant allografts, is supporting market growth. In addition, preservation techniques are essential to preserving organ quality and preventing transplant-associated death and morbidity.   

Breakup by Organ Type:

• Kidney
• Liver
• Lung
• Heart
• Others
   

Kidney exhibits a clear dominance in the market 

A detailed breakup and analysis of the market based on the organ type have also been provided in the report. This includes kidney, liver, lung, heart, and others. According to the report, kidney accounted for the largest market share.

The kidney is a vital part of the human body that benefits in removing waste products from the blood and producing urine. It regulates essential hormones in the body that help to control blood pressure, red blood cell (RBC) production, and calcium uptake from the intestine. It aids in maintaining a healthy balance of salts, water, and minerals, such as sodium, calcium, phosphorus, and potassium, in the blood of an individual. The rising prevalence of chronic kidney diseases (CKDs) is catalyzing the demand for kidney organs among individuals. The growing focus on organ preservation due to the increasing number of kidney transplant procedures is positively influencing the market. The number of patients with a functioning kidney transplant increased to 245,506 in 2021 as claimed by the U.S Department of Health and Human Services.

Breakup by End-User:

• Hospitals and Clinics
• Organ Banks
• Others
   

Organ banks dominate the market

The report has provided a detailed breakup and analysis of the market based on the end-user. This includes hospitals and clinics, organ banks, and others. According to the report, organ banks represented the largest segment.

Organ banks facilitate and manage various organs for transplant purposes. They serve as intermediaries between donors, donor families, hospitals, and transplant centers. They play a crucial role in ensuring the timely and efficient retrieval of organs from donors. They assist in coordinating the organ donation process and educating the public about donation. They also benefit in streamlining the donation process and increasing the chances of successful organ procurement.

Breakup by Region:

• North America
  • United States
  • Canada
• Asia Pacific
  • China
  • Japan
  • India
  • South Korea
  • Australia
  • Indonesia
  • Others
• Europe
  • Germany
  • France
  • United Kingdom
  • Italy
  • Spain
  • Russia
  • Others
• Latin America
  • Brazil
  • Mexico
  • Others
• Middle East and Africa
   

North America leads the market, accounting for the largest organ preservation market share

The report has also provided a comprehensive analysis of all the major regional markets, which include North America (the United States and Canada); Asia Pacific (China, Japan, India, South Korea, Australia, Indonesia, and others); Europe (Germany, France, the United Kingdom, Italy, Spain, Russia, and others); Latin America (Brazil, Mexico, and others); and the Middle East and Africa. According to the report, North America represents the largest regional market for organ preservation.

North America has a well-established healthcare infrastructure, including specialized care facilities, advanced hospitals, clinics, and medical research institutes. In addition, the rising awareness among healthcare providers about the importance of enhanced patient health is supporting the market growth. Besides this, favorable government initiatives are bolstering the growth of organ preservation market. For example, the Biostasis Research Institute (BRI) unveiled that it is establishing and funding two new research centers at Massachusetts General Hospital and the University of Minnesota on 21 April 2021. BRI is focusing on creating human organ banks through the cryogenic storage of organs donated for transplantation.

Competitive Landscape:

• The organ preservation market research report has also provided a comprehensive analysis of the competitive landscape in the market. Detailed profiles of all major companies have also been provided. Some of the major market players in the organ preservation industry include 21st Century Medicine Inc., Biolife Solutions Inc., Bridge to Life Ltd., Bristol-Myers, Dr. Franz Köhler Chemie GmbH, Essential Pharmaceuticals LLC, Lifeline Scientific Inc., OrganOx Ltd., Paragonix Technologies Inc., Transmedics, Inc., Waters Medical Systems LLC, and Xvivo Perfusion.
• Key players in the market are receiving approvals from governing authorities, which are supporting the market growth. For instance, TransMedics Group, Inc., a medical technology company announced that the U.S. Food and Drug Administration (FDA) granted premarket approval (PMA) of its OCS™ Heart System for use with organs from donors after circulatory death (DCD) on 28 April 2022. Moreover, X-Therma announced that the Center for Devices and Radiological Health (CDRH) of the US Food and Drug Administration (FDA) granted its proprietary XT-ViVo organ preservation solution and TimeSeal organ transport device on 3 May 2022.

Organ Preservation Market News:

• 28 October 2021, Paragonix Technologies announced the clinical and commercial launch of LIVERguard™ Donor Liver Preservation System in the United States and Europe, along with the launch of its clinical global registry, GUARDIAN-LIVER. The system provides a highly controlled and advanced environment for hypothermic liver preservation.
• 12 July 2021, Institut Georges Lopez (IGL), a French medical technology company, established a facility to manufacture medical devices and solutions for flushing and preservation of organs in Cheyyar, Tamil Nadu. The new facility enables more life-saving transplant procedures through improved quality and length of preservation.

Organ Preservation Market Scope:

Key Benefits for Stakeholders:

• IMARC’s industry report offers a comprehensive quantitative analysis of various market segments, historical and current market trends, market forecasts, and dynamics of the organ preservation market from 2018-2032.
• The research report provides the latest information on the market drivers, challenges, and opportunities in the global organ preservation market.
• The study maps the leading, as well as the fastest-growing, regional markets. It further enables stakeholders to identify the key country-level markets within each region.
• Porter's five forces analysis assists stakeholders in assessing the impact of new entrants, competitive rivalry, supplier power, buyer power, and the threat of substitution. It helps stakeholders to analyze the level of competition within the organ preservation industry and its attractiveness.
• The competitive landscape allows stakeholders to understand their competitive environment and provides insight into the current positions of key players in the market.